According to Pfizer's trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression i...

The European Medicines Agency (EMA) will this week give the green light to the treatment developed by U.S. biotech firm Regeneron and Swiss...

Till now, only Gilead's antiviral, remdesivir, is the only COVID-19 treatment that has been approved for use in EU. Japanese regulators app...

The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.

The approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid...